Feed GRFS
GR
Grifols
GRFS · NASDAQ
$7.88 +0.45% (+$0.04)
1M +1.25%
Market Cap 5.8B €
P/E Ratio 15.67x
Div. Yield 3.43%
ROE 6.81%
Bulios Fair Price
$181.63
2204.9% upside
Current Price
$7.88
Undervalued Fair Value Overvalued
Valuation
79 /100
Cheap P/E 15.67x
EV/EBITDA 9.66x
P/S 0.78x
Growth
63 /100
Stable EPS growth 22.51%
Rev. growth 6.02%
Book val. growth 2.29%
Profitability
48 /100
Moderate Gross margin 39.46%
Net margin 4.96%
Op. margin 18.26%
Quality
9 /100
Poor ROIC 4.80%
ROE 6.81%
ROA 1.87%
Debt
19 /100
High Debt/Equity 1.87x
Current ratio 2.48x
Int. coverage 2.58x
Stability
58 /100
Moderate Beta 1.18x
Rev. volatility 5.13%
EPS volatility 128.61%
Ask StockBot about GRFS
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Jose Ignacio Abia Buenache
Employees
23,833
Headquarters
Barcelona
Upcoming events
28 JUL
Earnings
Upcoming earnings report